Differential Expression of Human Lysyl Hydroxylase Genes, Lysine Hydroxylation, and Cross-linking of Type I Collagen During Osteoblastic Differentiation in Vitro
Overview
Affiliations
The pattern of lysyl hydroxylation in the nontriple helical domains of collagen is critical in determining the cross-linking pathways that are tissue specific. We hypothesized that the tissue specificity of type I collagen cross-linking is, in part, due to the differential expression of lysyl hydroxylase genes (Procollagen-lysine,2-oxyglutarate,5-dioxygenase 1, 2, and 3 [PLOD1, PLOD2, and PLOD3]). In this study, we have examined the expression patterns of these three genes during the course of in vitro differentiation of human osteoprogenitor cells (bone marrow stromal cells [BMSCs]) and normal skin fibroblasts (NSFs). In addition, using the medium and cell layer/matrix fractions in these cultures, lysine hydroxylation of type I collagen alpha chains and collagen cross-linking chemistries have been characterized. High levels of PLOD1 and PLOD3 genes were expressed in both BMSCs and NSFs, and the expression levels did not change in the course of differentiation. In contrast to the PLOD1 and PLOD3 genes, both cell types showed low PLOD2 gene expression in undifferentiated and early differentiated conditions. However, fully differentiated BMSCs, but not NSFs, exhibited a significantly elevated level (6-fold increase) of PLOD2 mRNA. This increase coincided with the onset of matrix mineralization and with the increase in lysyl hydroxylation in the nontriple helical domains of alpha chains of type I collagen molecule. Furthermore, the collagen cross-links that are derived from the nontriple helical hydroxylysine-aldehyde were found only in fully differentiated BMSC cultures. The data suggests that PLOD2 expression is associated with lysine hydroxylation in the nontriple helical domains of collagen and, thus, could be partially responsible for the tissue-specific collagen cross-linking pattern.
Zhai Z, Wang S, Cao Y, Liu J, Zhao Q, Ji Y Biomedicines. 2025; 12(12.
PMID: 39767559 PMC: 11673125. DOI: 10.3390/biomedicines12122653.
Generation of bone-specific lysyl hydroxylase 2 knockout mice and their phenotypes.
Tsuneizumi K, Kasamatsu A, Saito T, Fukushima R, Taga Y, Mizuno K Biochem Biophys Rep. 2024; 39:101790.
PMID: 39156722 PMC: 11327825. DOI: 10.1016/j.bbrep.2024.101790.
Macromolecular crowding in human tenocyte and skin fibroblast cultures: A comparative analysis.
Djalali-Cuevas A, Rettel M, Stein F, Savitski M, Kearns S, Kelly J Mater Today Bio. 2024; 25:100977.
PMID: 38322661 PMC: 10846491. DOI: 10.1016/j.mtbio.2024.100977.
Berg T, Doppelt-Flikshtain O, Coyac B, Zigdon-Giladi H Front Pharmacol. 2023; 14:1172705.
PMID: 37637413 PMC: 10450747. DOI: 10.3389/fphar.2023.1172705.
Reviewing the Regulators of COL1A1.
Devos H, Zoidakis J, Roubelakis M, Latosinska A, Vlahou A Int J Mol Sci. 2023; 24(12).
PMID: 37373151 PMC: 10298483. DOI: 10.3390/ijms241210004.